WuXi XDC faced significant shareholder sell-off, with the stock price dropping nearly 7% at one point
I'm PortAI, I can summarize articles.
藥明合聯（2268）股東合全藥業香港投資有限公司大手減持 5,080 萬股，涉資 21.78 億元，每股作價 42.88 元，較前日收市價折讓 6.78%。受此消息影響，藥明合聯股價一度跌近 7%，最低至 42.85 元，現報 44.5 元，跌幅 3.3%。同系藥明康德（2359）及藥明生物（2269）分別跌 0.4% 及 0.3%。
港交所資料顯示，藥明合聯（2268）今早有一宗大手交易，涉資 21.78 億元或 5,080 萬股，每股作價 42.88 元，較上日收市價 46 元折讓 6.78%。受消息影響，藥明合聯股價曾跌 6.84% 至 42.85 元，其後跌幅收窄；暫報 44.5 元，跌 3.3%。同系藥明康德（2359）及藥明生物（2269）則分別跌 0.4% 及 0.3%。
據彭博引述交易條款報道，藥明合聯的股東合全藥業香港投資有限公司對減持規模擴大至 5,080 萬股，定價為每股 42.88 元，涉資 21.78 億元，相關股份佔已發行股份總數 4.2%，賣方禁售期為 90 天。
Source: 星島網 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments